References
- Abbas R.Z., Qureshi M.A., Saeed Z. (2025). Botanical compounds: A promising control strategy against Trypanosoma cruzi. Bolet. Latinoam.y Carib. Plant. Medicina. Aromát., 24: 308–27.
- Abd El-Ghany W.A., Shaalan M., Salem H.M. (2021). Nanoparticles applications in poultry production: an updated review. World. Poult. Sci. J., 77: 1001–1025.
- Abolnik C. (2017). History of newcastle disease in South Africa. Onderstepoort J. Vet. Res., 84: 1–7.
- Afzal Z., Javed M.T., Mohsin M., Ahmad H.M.W., Saeed Z., Taimoor M., Aleem R.A., Raza A.,
- Ayub A., Israr F. (2024). The usefulness of glutaraldehyde coagulation test as a conjuncture test in the diagnosis of tuberculosis in humans and animals. Agrobiol. Rec., 15: 34–40.
- Akhtar T., Shahid S., Asghar A., Naeem M.I., Aziz S., Ameer T. (2023). Utilisation of herbal bullets against Newcastle disease in poultry sector of Asia and Africa (2012–2022). Int. J. Agri. Biosci., 12: 56–65.
- Ahmad R., Abbas R.Z., Özlem K., Abdul R., Arslan, M.A., Muhammad, Z.K., Nimra, M., Ayesha, Q., Aneela H., Kostadin P.K. (2024). Role of probiotics in increasing meat and egg production in poultry: a review. Kafkas. Univ. Vet. Fak. Derg., 30: 753–760.
- Almuzaini A.M. (2024). A review on the use of nanomaterials for control and prevention of Clostridium perfringens: an organism of zoonotic importance. Pak. Vet. J., 44: 563–570.
- Alexander D.J. (2011). Newcastle disease in the European Union 2000 to 2009. Avian Pathol., 40: 547–558.
- Alkhalefa N., Khaliel S., Tahoon A., Shaban H., Magouz A., Ghabban H., Lokman M.S., Elmahallawy E.K. (2022). In vitro investigation of the antiviral activity of propolis and chitosan nanoparticles against the genotype VII Newcastle disease virus. Front. Vet. Sci., 9: 947641.
- Altaf S., Iqbal T., Salma U., Sajid M., Basit I., Sabir M.Z., Riaz K., Rasheed R., Umair M., Talha R. (2024). Gold nanoparticles for the detection of organophosphate. Agrobiol. Rec., 16: 11–18.
- Anwar M.I., Awais M.M., Akhtar M., Navid M.T., Muhammad F. (2019). Nutritional and immunological effects of nano-particles in commercial poultry birds. World. Poult. Sci. J., 75: 261–272.
- Bashir F., Sharif S., Manzoor F., Naz S., Rashid F. (2024). Protective Effects of Moringa oleifera leaf extract against silver nanoparticles and arsenic induced hepatotoxicity in rats. Pak. Vet. J., 44: 377–383.
- Bakshi P.S., Selvakumar D., Kadirvelu K., Kumar N.S. (2020). Chitosan as an environment friendly biomaterial–a review on recent modifications and applications. Int. J. Biologic. Macromol., 150: 1072–1083.
- Bello M.B., Yusoff K., Ideris A., Hair-Bejo M., Peeters B.P.H., Omar A.R. (2018). Diagnostic and vaccination approaches for Newcastle disease virus in poultry: The current and emerging perspectives. BioMed. Res. Int., 2018: 317.
- Bhanja S.K., Rath P.K., Goel A., Mehra M., Dhara S.K., Paswan V.K., Attia Y.A., Alqhtani A.H., Ali A.B.A., Shehata A.M. (2022). In ovo nano-silver and nutrient supplementation improves immunity and resistance against Newcastle disease virus challenge in broiler chickens. Front. Vet. Sci., 9: 948069.
- Biswas M., Nurunnabi M., Khatun Z. (2024). Understanding mucosal physiology and rationale of formulation design for improved mucosal immunity. ACS Appl. Biol. Mater., 7: 5037– 5056.
- Boroumand H., Badie F., Mazaheri S., Seyedi Z.S., Nahand J.S., Nejati M., Baghi H.B., Abbasi-Kolli M., Badehnoosh B., Ghandali M. (2021). Chitosan-based nanoparticles against viral infections. Front. Cellu. Infect. Micro., 11: 643953.
- Brown V.R., Bevins S.N. (2017). A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread. Vet. Res., 48: 1–15.
- Cem Ö., Barış Y., Ramazan D., Özkan Ö. (2024). Effects of zinc oxide nanoparticles on pyruvate dehydrogenase and lactate dehydrogenase expressions and apoptotic index in breast cancer cells. Kafkas. Univ. Vet. Fak. Derg., 30: 489–496.
- Dai C., Kang H., Yang W., Sun J., Liu C., Cheng G., Rong G., Wang X., Wang X., Jin Z. (2015). O-2′-hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine. Carb. Polym., 130: 280–289.
- de Alvarenga E.S. (2011). Characterization and properties of chitosan. Biotech. Biopolym., 91: 48–53.
- Desai N., Rana D., Salave S., Gupta R., Patel P., Karunakaran B., Sharma A., Giri J., Benival D., Kommineni N. (2023). Chitosan: A potential biopolymer in drug delivery and biomedical applications. Pharmaceutics, 15: 1313.
- Dharmayanti N.L.P.I., Nurjanah D., Nuradji H., Suyatno T., Indriani R. (2024). Newcastle disease virus: the past and current situation in Indonesia. J. Vet. Sci., 25: e3.
- Diaz-Arévalo D., Zeng M. (2020). Nanoparticle-based vaccines: opportunities and limitations, Nanopharmaceuticals. Elsevier, 1: 135–150.
- Dilnawaz F., Acharya S., Kanungo A. (2024). A clinical perspective of chitosan nanoparticles for infectious disease management. Polym. Bullet., 81: 1071–1095.
- Dmour I., Islam N. (2022). Recent advances on chitosan as an adjuvant for vaccine delivery. Int. J. Biologic. Macromol., 200: 498–519.
- Dzogbema K.F.-X., Talaki E., Batawui K.B., Dao B.B. (2021). Review on Newcastle disease in poultry. Int. J. Biologic. Chem. Sci., 15: 773–789.
- Elbehary M., Dowidar Y.A., Ashour A.M., El-Fattah E.M.A., Monir A. (2023). Effect of in vitro maturation medium supplementation with chitosan nanoparticles on the river buffalo cumulus-oocyte complexes. Int. J. Vet. Sci., 12: 341–346.
- El-Hamaky A.M.A., Hassan A.A., Wahba A.K.A., El-Mosalamy M.M.E.A. (2023). Influence of copper and zinc nanoparticles on genotyping characterizations of multi-drug resistance genes for some calf pathogens. Int. J. Vet. Sci., 12: 309–317.
- El-Qabbany M.M., Metwally K.M., Aly I.R., Mahmoud S., El-Menyawy H.M., Sadek A.-S.M. (2024). Estimation of certain biochemical and immune system responses in mice with schistosoma mansoni infection and treated with mefloquine, praziquantel and chitosan nanoparticles. Int. J. Vet. Sci., 13: 51–57.
- Elsoud M.M.A., Elmansy E.A., Abdelhamid S.A. (2022). Economic and non-seasonal source for production of chitin and chitosan. J. Chem. Rev., 4: 222–240.
- Freitas E.D., Moura Jr C.F., Kerwald J., Beppu M.M. (2020). An overview of current knowledge on the properties, synthesis and applications of quaternary chitosan derivatives. Polymers, 12: 2878.
- Gong X., Gao Y., Shu J., Zhang C., Zhao K. (2022). Chitosan-based nanomaterial as immune adjuvant and delivery carrier for vaccines. Vaccines, 10: 1906.
- Gourbal B., Pinaud S., Beckers G.J.M., Van Der Meer J.W.M., Conrath U., Netea M.G. (2018). Innate immune memory: An evolutionary perspective. Immunol. Rev., 283: 21–40.
- Haddas R. (2023). Newcastle disease virus. Infect. Dis., 2023: 427.
- Hannan A., Du X.X., Maqbool B., Khan A. (2024). Nanoparticles as potent allies in combating antibiotic promising frontier in antimicrobial therapy. Pak. Vet. J., 44: 957–967.
- Hahn T., Tafi E., Paul A., Salvia R., Falabella P., Zibek S. (2020). Current state of chitin purification and chitosan production from insects. J. Chem. Technol. Biotech., 95: 2775– 2795.
- Hamza A.A., Ali B.H., Albayati M.A. (2020). Reformulation of newcastle disease vaccine using chitosan nanoparticles in broiler. Plant Archive., 20: 2285–2290.
- Hayajneh F., Abdelqader A., Araj S., Zakaria H., JAl-Khazaleh, Irshaid R. (2024). Subclinical Clostridium perfringens infection and Marek’s Disease in Jordanian broiler chickens. Int. J. Vet. Sci., 13: 132–138.
- He X., Xing R., Li K., Qin Y., Zou P., Liu S., Yu H., Li P. (2016). Beta-chitosan extracted from Loligo Japonica for a potential use to inhibit Newcastle disease. Int. J. Biologic. Macromol., 82: 614–620.
- He X., Xing R., Liu S., Qin Y., Li K., Yu H., Li P. (2021). The improved antiviral activities of amino-modified chitosan derivatives on Newcastle virus. Drug Chem. Toxicol., 44: 335– 340.
- Hongzhuan Z., Ying T., Xia S., Jinsong G., Zhenhua Z., Beiyu J., Yanyan C., Lulu L., Jue Z., Bing Y. (2020). Preparation of the inactivated Newcastle disease vaccine by plasma activated water and evaluation of its protection efficacy. Applied Microbiol. Biotech., 104: 107–117.
- Hu Z., He X., Deng J., Hu J., Liu X. (2022). Current situation and future direction of Newcastle disease vaccines. Vet. Res., 53: 99.
- Hussain J., Rabbani I., Aslam S., Ahmad H.A. (2015). An overview of poultry industry in Pakistan. World. Poult. Sci. J., 71: 689–700.
- Iqbal T., Altaf S., Fatima M., Rasheed R., Laraib K., Azam M., Karamat M., Salma U., Usman S. (2024 a). A narrative review on effective use of medicinal plants for the treatment of parasitic foodborne diseases. Agrobiol. Rec., 16: 79–92.
- Iqbal R., Irfan M., Bibi A., Batool E., Ahmad R., Ammat-u-Salam, Afzal M. (2024). Impacts of ZnO nanoparticles on brain and spleen in male albino rats, A comprehensive exploration of diverse exposure routes. Continental Vet. J., 4: 92–100.
- Iqbal T., Altaf S., Salma U., Fatima M., Khan M.N., Farooq S., Abrar M., Tasleem M., Afzal A. (2024 b). Cell membrane coated polymeric nanocarriers: a novel drug delivery approach for the targeted therapy of rheumatoid arthritis. Agrobiol. Rec., 15: 91–102.
- Issar U., Arora R. (2022). Antiviral potency of chitosan, its derivatives, and nanocomposites, chitosan-based nanocomposite materials: Fabrication, characterization and biomedical applications. Springer, pp. 273–289.
- Ivanov S., Merlin J., Lee M.K.S., Murphy A.J., Guinamard R.R. (2018). Biology and function of adipose tissue macrophages, dendritic cells and B cells. Atherosclerosis, 271: 102–110.
- Jhaveri J., Raichura Z., Khan T., Momin M., Omri A. (2021). Chitosan nanoparticles-insight into properties, functionalization and applications in drug delivery and theranostics. Molecule, 26: 272.
- Jin Z., Li D., Dai C., Cheng G., Wang X., Zhao K. (2017). Response of live Newcastle disease virus encapsulated in N-2-hydroxypropyl dimethylethyl ammonium chloride chitosan nanoparticles. Carb. Polymer., 171: 267–280.
- Kade Suardana I.B., Widyastuti S.K., Krisna Pradnyadana I.B., Agustina K.K. (2023). Effect of age and presence of maternal antibodies on success of avian influenza and Newcastle Disease vaccinations in broiler. Int. J. Vet. Sci., 12: 101–106.
- Kamal M.A., Khalaf M.A., Ahmed Z.A.M., Fathy M., El-Miniawy H.M.F., Mahmoud A.M., Osman A., Zaki E.M.A. (2023). Effect of water organic load and total ammonia nitrogen on broilers’ humoral immune response against Newcastle disease virus vaccination in Egypt. Int. J. Vet. Sci., 12: 107–113.
- Kang M.L., Cho C.S., Yoo H.S. (2009). Application of chitosan microspheres for nasal delivery of vaccines. Biotech. Adv., 27: 857–865.
- Khan S.R., Iqbal R., Hussain R., Ali M., Khalid M., Nazish N., Naqvi S.S. (2024). Broccoli partially lowers oxidative stress, histopathological lesions and enhances antioxidant profile of mono sex Tilapia exposed to zinc oxide nanoparticles. Pak. Vet. J., 44: 306–313.
- Kou S.G., Peters L.M., Mucalo M.R. (2021). Chitosan: A review of sources and preparation methods. Int. J. Biologic. Macromol., 169: 85–94.
- Liaqat I., Omer M.O., Rasheed M.A., Raza S. (2024). Preparation, characterization and in vitro anticancer evaluation of albendazole-loaded zinc oxide nanoparticles. Pak. Vet. J., 44: 1338–1344.
- Li J., Cai C., Li J., Li J., Li J., Sun T., Wang L., Wu H., Yu G. (2018). Chitosan-based nanomaterials for drug delivery. Molecule, 23: 2661.
- Li X., Xing R., Xu C., Liu S., Qin Y., Li K., Yu H., Li P. (2021). Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants. Carb. Polym., 264: 118050.
- Lima R., Fernandes C., Pinto M.M.M. (2022). Molecular modifications, biological activities, and applications of chitosan and derivatives: A recent update. Chirality, 34: 1166–1190.
- Lin S.-Y., Yao B.Y., Hu C.-M.J., Chen H.-W. (2020). Induction of robust immune responses by CpG-ODN-loaded hollow polymeric nanoparticles for antiviral and vaccine applications in chickens. Int. J. Nanomed., 15: 3303–3318.
- Maqsood R., Ali A., Sial B.E., Aslam N., Mehmood Y., Mustafa G., Sohail T., Farhab M. (2023). In vivo and in vitro genotoxic effects of Zinc Oxide Nanoparticles (ZnO NPs): A comprehensive review. Continental Vet. J., 3: 1–14.
- Mebrahtu K., Teshale S., Esatu W., Habte T., Gelaye E. (2018). Evaluation of spray and oral delivery of Newcastle disease I2 vaccine in chicken reared by smallholder farmers in central Ethiopia. BMC Vet. Res., 14: 1–7.
- Mohammadi A., Moghaddam A.Z., Shahsavandi S. (2021 a). Evaluation of humoral and cellular immune responses of chitosanbased Newcastle nanoparticles vaccination with homokinin-1 molecular adjuvant. Iran. J. Vet. Clinic. Sci., 15: fa103–fa112
- Mohammadi A.R., Zamani Moghaddam A., Shahsavandi S. (2021 b). Encapsulation of inactivated Newcastle disease virus onto the chitosan nanoparticles for use in mucosal immunity. Iran. J. Virol., 15: 32–39.
- Moine L., Canali M.M., Porporatto C., Correa S.G. (2021). Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity. Int. J. Biologic. Macromol., 189: 324–334.
- Mura P., Maestrelli F., Cirri M., Mennini N. (2022). Multiple roles of chitosan in mucosal drug delivery: an updated review. Marine Drug., 20: 335.
- Mustafa S., Abbas R.Z., Saeed Z., Baazaoui N., Khan A.M.A. (2024). Use of metallic nanoparticles against Eimeria – the coccidiosis causing agents: A comprehensive review. Biol. Trac. Elem. Res., 2024: 1–20.
- Nakamura Y., Kimura S., Hase K. (2018). M cell-dependent antigen uptake on follicle-associated epithelium for mucosal immune surveillance. Inflam. Regen., 38: 1–9.
- Omidian H., Gill E.J., Dey Chowdhury S., Cubeddu L.X. (2024). Chitosan nanoparticles for intranasal drug delivery. Pharmaceuticals, 16: 746.
- Park I.K., Jiang H.L., Yun C.H., Choi Y.J., Kim S.J., Akaike T., Kim S.I., Cho C.S. (2004). Release of Newcastle disease virus vaccine from chitosan microspheres in vitro and in vivo. Asian-Australasian J. Anim. Sci., 17: 543–547.
- Prabhu P., Patravale V. (2014). Potential of nanocarriers in antigen delivery: the path to successful vaccine delivery. Nanocarriers, 1: 10–45.
- Qi H., Kastenmüller W., Germain R.N. (2014). Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue. Ann. Rev. Cell Develop. Biol., 30: 141–167.
- Rauw F., Gardin Y., Palya V., Anbari S., Gonze M., Lemaire S., van den Berg T., Lambrecht B. (2010 a). The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet. Immunol. Immunopathol., 134: 249–258.
- Rauw F., Gardin Y., Palya V., Anbari S., Lemaire S., Boschmans M., van den Berg T., Lambrecht B. (2010 b). Improved vaccination against Newcastle disease by an in ovo recombinant HVT-ND combined with an adjuvanted live vaccine at day-old. Vaccine, 28: 823–833.
- Reboldi A., Arnon T.I., Rodda L.B., Atakilit A., Sheppard D., Cyster J.G. (2016). IgA production requires B cell interaction with subepithelial dendritic cells in Peyer’s patches. Science, 352: aaf4822.
- Rehan M., Aslam A., Khan M.R., Abid M., Hussain S., Amber J., Anjum A., Hussain A. (2019). Potential economic impact of Newcastle disease virus isolated from wild birds on commercial poultry industry of Pakistan: A review. Hosts Virus., 6: 1–15.
- Renu S., Renukaradhya G.J. (2020). Chitosan nanoparticle based mucosal vaccines delivered against infectious diseases of poultry and pigs. Front. Bioeng. Biotech., 8: 558349.
- Rtishchev A., Treshchalina A., Shustova E., Boravleva E., Gambaryan A. (2023). An outbreak of Newcastle disease virus in the Moscow region in the summer of 2022. Vet. Sci., 10: 404. Saeed Z., Alkheraije K.A. (2023). Botanicals: A promising approach for controlling cecal coccidiosis in poultry. Front. Vet. Sci., 10:1157633.
- Shakoor S., Naeem S., Ramsha N.S., Rao A.Q., Shahid A.A. (2021). Recent trends in immunology and vaccination against Newcastle disease virus. Vet. Pathol. Pub. Health, 37: 441–449.
- Shawky Y.A., Hussein A., Salman O.G.A., Eid A.A.M. (2023). Enhancement of the immune response of chickens vaccinated with adjuvanted live Newcastle disease virus vaccine. Slovenian Vet. Res., 60: 185.
- Singh B., Maharjan S., Jiang T., Kang S.K., Choi Y.J., Cho C.S. (2015). Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine. Mol. Pharmaceut., 12: 3816–3828.
- Sultan S., Hamed M., Osman N. (2021). Evaluation of protection efficiency of different vaccination programs against velogenic Newcastle disease virus in broiler chickens: Comparative in field and in laboratory studies. Thai J. Vet. Med., 51: 141–150.
- Susalam M.K., Harnentis H., Marlida Y., Jamsari J., Ardani L.R. (2024). The effect of probiotics consortium isolated from fermented fish (Budu) on broiler performances and meat quality. Int. J. Vet. Sci., 13: 100–107.
- Solmaz K., Figen S.K., Mehmet K., Onur T., Ahmet N. (2024). Impact of early qualitative feed restriction and the provision of barrier perch on morphometric and biomechanical measurements of bones in broiler chickens. Kafkas Uni.Vet. Fak. Derg., 30: 619–629.
- Tiwari A., Swamy M., Mishra P. (2020). Avian immunity and immunopathology of avian diseases. J. Ento. Zoo. Study., 8: 484–492.
- Tomar R., Yadav S., Chauhan D.K. (2024). Haemato-biochemcial studies of nanoparticle-based vaccine against R2b strain of New Castle Disease in chicks. Int. J. Pharm. Pharmaceut. Sci., 16: 13–17.
- van Boven M., Bouma A., Fabri T.H.F., Katsma E., Hartog L., Koch G. (2008). Herd immunity to Newcastle disease virus in poultry by vaccination. Avian Pathol., 37: 1–5.
- Volkova M.A., Irza A.V., Chvala I.A., Frolov S.F., Drygin V.V., Kapczynski D.R. (2014). Adjuvant effects of chitosan and calcium phosphate particles in an inactivated Newcastle disease vaccine. Avian Dis., 58: 46–52.
- Wadhwa S., Paliwal R., Rai P.S., Vyas S. (2009). Chitosan and its role in ocular therapeutics. Mini Rev. Medicin. Chemist., 9: 1639–1647.
- Wang J., Zhuang S. (2022). Chitosan-based materials: Preparation, modification and application. J. Clean. Prod., 355: 131825.
- Wang W., Meng Q., Li Q., Liu J., Zhou M., Jin Z., Zhao K. (2020 a). Chitosan derivatives and their application in biomedicine. Int. J. Mol. Sci., 21: 487.
- Wang W., Xue C., Mao X. (2020 b). Chitosan: Structural modification, biological activity and application. Int. J. Biol. Macromol., 164: 4532–4546.
- Wu Y., Li N., Zhang T., Che Y., Duan K., Wang Y., Zhou H., Wan X., Lei H., Nguyễn A.D. (2022). Glycyrrhiza polysaccharides can improve and prolong the response of chickens to the Newcastle disease vaccine. Poult. Sci., 101: 101549.
- Xu C., Xing R., Liu S., Qin Y., Li K., Yu H., Li P. (2021). The immunostimulatory effects of hydroxypropyltrimethyl ammonium chloride chitosan-carboxymethyl chitosan nanoparticles. Int. J. Biologic. Macromol., 181: 398–409.
- Yakubogullari N., Coven F.O., Cebi N., Coven F., Coven N., Genc R., Bedir E., Nalbantsoy A. (2021). Evaluation of adjuvant activity of Astragaloside VII and its combination with different immunostimulating agents in Newcastle Disease vaccine. Biologicals, 70: 28–37.
- Yang Y., Xing R., Liu S., Qin Y., Li K., Yu H., Li P. (2020). Chitosan, hydroxypropyltrimethyl ammonium chloride chitosan and sulfated chitosan nanoparticles as adjuvants for inactivated Newcastle disease vaccine. Carb. Polym., 229: 115423.
- Yosif H.M., Hasoon, B.A., Jabir M.S., Yaqoob, S.H., Samir H, Swelum A.A. (2024). Antibacterial activity of laser ablated gold and hydroxyapatite nanoparticles conjugated cefuroxime against staphylococcus saprophyticus. Pak. Vet. J., 44: 38–46.
- Younas K., Khan R.A.A., Nauman A., Ali H., Elahi A., Khan A., Zahid R., Saeed H., Iqbal K., Huzaifa M.A. (2024). Effect of metallic and nonmetallic nanoparticles (NPs) and their salts in reproductive biotechnology. Continental. Vet. J., 4: 110–119.
- Zhang J., Ji Y., Wang Z., Jia Y., Zhu Q. (2022). Effective improvements to the live-attenuated Newcastle disease virus vaccine by polyethylenimine-based biomimetic silicification. Vaccine, 40: 886–896.
- Zhao J., Li J., Jiang Z., Tong R., Duan X., Bai L., Shi J. (2020). Chitosan, N, N, N-trimethyl chitosan (TMC) and 2-hydroxypropyltrimethyl ammonium chloride chitosan (HTCC): The potential immune adjuvants and nano carriers. Int. J. Biol. Macromol., 154: 339–348.
- Zhao K., Chen G., Shi X.-M., Gao T.-T., Li W., Zhao Y., Zhang F.-Q., Wu J., Cui X., Wang Y.- F. (2012). Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles. PloS One, 7: e53314.
- Zhao K., Han J., Zhang Y., Wei L., Yu S., Wang X., Jin Z., Wang Y. (2018). Enhancing mucosal immune response of Newcastle disease virus DNA vaccine using N-2-hydroxypropyl trimethylammonium chloride chitosan and N, O-carboxymethyl chitosan nanoparticles as delivery carrier. Mol. Pharmaceut., 15: 226–237.
- Zhao K., Li S., Li W., Yu L., Duan X., Han J., Wang X., Jin Z. (2017). Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration. Drug Delive., 24: 1574–1586.
- Zhao K., Sun B., Shi C., Sun Y., Jin Z., Hu G. (2021). Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens. J. Nanobiotech., 19: 1–15.
- Zhao K., Sun Y., Chen G., Rong G., Kang H., Jin Z., Wang X. (2016). Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine. Carb. Polym., 149: 28–39.
- Zhao K., Zhang Y., Zhang X., Li W., Shi C., Guo C., Dai C., Chen Q., Jin Z., Zhao Y. (2014). Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles. Int. J. Nanomed., 9: 389–402.